CSIMarket
 


Viewray Inc   (VRAY)
Other Ticker:  
 

Viewray Inc 's Leverage Ratio

VRAY's quarterly Leverage Ratio and Total Liabilities, Equity growth


In Spite of the repayements of liabilities of -5.95%, in I Quarter 2023 ,Leverage Ratio deteriorated to 3.22, below the Viewray Inc 's average Leverage Ratio.

Within Medical Equipment & Supplies industry in the first quarter 2023, 180 other companies have achieved lower Leverage Ratio than Viewray Inc in the I Quarter 2023. While Leverage Ratio total ranking has deteriorated compared to the forth quarter 2022 from 1663 to 3304 .

Explain Leverage Ratio?
Who are VRAY Customers?
What are VRAY´s Total Liabilities?


VRAY Leverage Ratio (Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Dec 31 2021)
IV. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
Y / Y Equity Change -66.39 % -36.87 % 12.42 % -20.1 % -15.26 %
Y / Y Total Liabilities Change 44.07 % 44.08 % 9.32 % 4.39 % -1 %
Leverage Ratio MRQ 3.22 2.3 0.9 0.97 0.75
VRAY's Total Ranking # 3304 # 1663 # # #
Seq. Equity Change -32.81 % -51.56 % 22.11 % -15.42 % 26.21 %
Seq. Total Liabilities Change -5.95 % 24.43 % 12.75 % 9.18 % -5.94 %



Leverage Ratio first quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 181
Healthcare Sector # 857
Overall Market # 3304


Leverage Ratio Statistics
High Average Low
56.02 4.23 0.59
(Dec 31 2017)   (Sep 30 2018)




Financial Statements
Viewray Inc 's Equity $ 55 Millions Visit VRAY's Balance sheet
Viewray Inc 's Total Liabilities $ 178 Millions Visit VRAY's Balance sheet
Source of VRAY's Sales Visit VRAY's Sales by Geography


Cumulative Viewray Inc 's Leverage Ratio

VRAY's Leverage Ratio for the trailling 12 Months

VRAY Leverage Ratio

(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Dec 31 2021)
IV. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
Y / Y Equity TTM Growth -66.39 % -36.87 % 12.42 % -20.1 % -15.26 %
Y / Y Total Liabilities TTM Growth 44.07 % 44.08 % 9.32 % 4.39 % -1 %
Leverage Ratio TTM 1.46 1.08 0.9 0.9 0.84
Total Ranking TTM # 3265 # 9 # # #
Seq. Equity TTM Growth -32.81 % -51.56 % 22.11 % -15.42 % 26.21 %
Seq. Total Liabilities TTM Growth -5.95 % 24.43 % 12.75 % 9.18 % -5.94 %


On the trailing twelve months basis Despite of the repayements of liabilities of -5.95% in the trailing twelve months ending in I Quarter 2023, Leverage Ratio improved to 1.46, above Viewray Inc 's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Medical Equipment & Supplies industry 184, during the past 12 months, other companies have achieved lower Leverage Ratio than Viewray Inc . While Leverage Ratio total ranking has deteriorated during the twelve months ending in the I Quarter 2023, compared to the prior period, from 9 to 3265.

Explain Leverage Ratio?
Who are VRAY Customers?
What are VRAY´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 185
Healthcare Sector # 866
Within the Market # 3265


trailing twelve months Leverage Ratio Statistics
High Average Low
2.54 1.25 0.82
(Mar 31 2017)   (Mar 31 2020)




Companies with similar Leverage Ratio in the quarter ending Mar 31 2023, within Medical Equipment & Supplies Industry Leverage RatioMar 31 2023 MRQ Total LiabilitiesMar 31 2023 MRQ Equity
Pavmed Inc   7.60 $ 82.143  Millions$ 10.804  Millions
Invacare Holdings Corporation  7.09 $ 325.833  Millions$ 45.939  Millions
The Beauty Health Company  5.70 $ 842.379  Millions$ 147.664  Millions
Plus Therapeutics Inc   4.78 $ 12.796  Millions$ 2.676  Millions
Owens and Minor inc  4.45 $ 4,116.428  Millions$ 924.400  Millions
Biolase Inc   4.14 $ 33.786  Millions$ 8.158  Millions
American International Holdings Corp   4.13 $ 8.870  Millions$ 2.149  Millions
Baxter International Inc   3.77 $ 22,412.000  Millions$ 5,941.000  Millions
Insulet Corporation  3.54 $ 1,780.300  Millions$ 502.800  Millions
Viewray Inc   3.22 $ 177.902  Millions$ 55.257  Millions
Yunhong Green Cti Ltd   3.10 $ 12.527  Millions$ 4.035  Millions
The Pennant Group Inc   2.97 $ 383.724  Millions$ 129.224  Millions
Bioventus Inc   2.91 $ 698.893  Millions$ 240.362  Millions
Neuropace Inc   2.81 $ 77.315  Millions$ 27.490  Millions
Cerus Corporation  2.57 $ 150.704  Millions$ 58.632  Millions
Petvivo Holdings Inc  2.36 $ 1.714  Millions$ 0.725  Millions
Uphealth Inc   2.28 $ 236.591  Millions$ 103.599  Millions
Tenon Medical Inc   2.08 $ 5.155  Millions$ 2.474  Millions
Therapeutic Solutions International Inc   2.05 $ 2.385  Millions$ 1.165  Millions
3m Company  2.00 $ 30,698.000  Millions$ 15,351.000  Millions
Conmed Corporation  2.00 $ 1,502.121  Millions$ 752.453  Millions
Escalon Medical Corp   1.95 $ 3.384  Millions$ 1.736  Millions
Vaso Corporation  1.86 $ 43.554  Millions$ 23.357  Millions
Msa Safety Incorporated  1.83 $ 1,409.924  Millions$ 769.746  Millions
U S Physical Therapy Inc  1.72 $ 548.651  Millions$ 319.476  Millions
Tandem Diabetes Care Inc   1.71 $ 578.779  Millions$ 338.753  Millions
Artivion Inc   1.70 $ 477.156  Millions$ 279.917  Millions
Biosig Technologies Inc   1.63 $ 3.116  Millions$ 1.910  Millions
Soleno Therapeutics Inc  1.59 $ 4.192  Millions$ 2.639  Millions
Iridex Corp  1.58 $ 25.096  Millions$ 15.884  Millions

Date modified: 2023-04-03T19:20:56+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com